Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2004 | 10-2003 | 07-2003 | 04-2003 | 01-2003 | |
| Sales | 1,038 | 1,363 | 0 | 660 | 833 |
| Cost of Goods | 588 | 559 | N/A | 707 | 671 |
| Gross Profit | 450 | 804 | N/A | -48 | 162 |
| Operating Expenses | 973 | 1,018 | 0 | 1,209 | 1,305 |
| Operating Income | 64 | 345 | N/A | -550 | -472 |
| Other Income | 0 | 0 | 0 | 4 | -938 |
| Pre-tax Income | 64 | 345 | 0 | -546 | -1,410 |
| Net Income Continuous | 64 | 345 | N/A | -546 | -1,410 |
| Net Income | $64 | $345 | $N/A | $-546 | $-1,410 |
| EPS Basic Total Ops | 0.01 | 0.06 | N/A | -0.09 | -0.23 |
| EPS Basic Continuous Ops | 0.01 | 0.06 | N/A | -0.09 | -0.23 |
| EPS Diluted Total Ops | 0.01 | 0.06 | N/A | -0.09 | -0.23 |
| EPS Diluted Continuous Ops | 0.01 | 0.06 | N/A | -0.09 | -0.23 |
| EBITDA(a) | $95 | $361 | $N/A | $-424 | $-456 |